Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders

Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders

Background: Chronic lymphoproliferative disorders (CLPDs) are heterogeneous group of disorders with variable clinical presentations and outcomes. Therefore, accurate classification is crucial for treatment planning. At present, flow cytometry immunophenotyping (FCM-IPT) is a useful tool for diagnosi...

Full description

Bibliographic Details
Main Authors: R Poongodi, Neelam Varma, Shano Naseem, Bose Parveen, Subhash Varma
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Indian Journal of Pathology and Microbiology
Subjects:
CD20 antibody binding capacity
CD200
chronic lymphoproliferative disorders
Online Access:http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2018;volume=61;issue=1;spage=50;epage=57;aulast=Poongodi

Internet

http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2018;volume=61;issue=1;spage=50;epage=57;aulast=Poongodi

Similar Items